A nurse is reinforcing teaching about laboratory testing with a client who has a prescription for clozapine. Which of the following laboratory tests should the nurse instruct the client to undergo weekly for the first 6 months of treatment?

A. Clozapine can affect metabolic parameters, but fasting glucose is not required weekly for the first 6 months. B. Clozapine carries a risk of agranulocytosis, a potentially life-threatening decrease in white blood cells. Weekly monitoring of the WBC count (and absolute neutrophil count) is required during the initial 6 months of therapy to detect early signs of bone marrow suppression. C. Platelet count monitoring is not the primary concern with clozapine therapy. D. Uric acid levels are not routinely monitored for clients taking clozapine.